Filter posts

Five Oncologists Weigh in on Value Frameworks

Value Frameworks, which attempt to quantify the value of a medicine, have been a hot …

13 Days Until BIO 2015: Moneyball: Acing the Big Pharma/Small Biotech Deal

In just a few weeks, thousands of players in the pharma and biotech industry will …

What to Watch: Emperor of All Maladies; Killing Cancer

Cancer is a disease which affects almost 1.7 million people each year in America, and …

Integrate and Collaborate to Drive Advancements in Oncology Treatments

Scientific innovation and exploration have driven exciting changes in the pharmaceutical industry‚Äôs understanding of cancer, …

Post-Con BIO CEO Company Snapshot: Immunovaccine

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. …

BIO CEO: Five Prime Therapeutics Company Snapshot

Five Prime Therapeutics is another company that will be presenting at next week’s BIO CEO …

BIO Investor Forum Company Snapshot: Opsona Therapeutics

Opsona Therapeutics will be participating in the upcoming BIO Investor Forum, and will be giving …

BIO Investor Forum Company Snapshot: Vaccinex

Recently, the CEO of Prosensa provided their company’s perspective¬†participating in last year’s BIO Investor Forum. …

BIO Investor Forum Company Snapshot: DLVR Therapeutics

DLVR Therapeutics will be presenting in the Discovery Company Track at the upcoming BIO Investor …

Medicare Part B: Barriers to Cancer Treatment

The National Patient Advocate Foundation (PAF) has seen a notable rise in calls for assistance …